Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Pre-BCR Surrogate Light Chain Components VPREB1 and IGLL1 Function As Pre-BCR-Independent Tumor Suppressors in Acute Lymphoblastic Leukemia

Kadriye Nehir Cosgun, PhD, Rudi W Hendriks, PhD, Ross A Dickins, PhD, Nora Heisterkamp, PhD, Markus Muschen, MD

Blood (2018) 132 (Supplement 1): 570.

https://doi.org/10.1182/blood-2018-99-115522

Published: 2018

Journal Articles

CAR T Cell Relapse CD19 Negative ALL Cells Express Integrins and Integrin Blockade Can Prolong Survival In Vivo

Hye Na Kim, Solah Lee, Kristen Fousek, BS, MS, Shuangyue Li, Anne Kim, Junji Watanabe, PhD, Halvard Bonig, MD MA, Nabil Ahmed, MD, Hisham Abdel-Azim, Nora Heisterkamp, PhD, Yong-Mi Kim, MD MPH, PhD

Blood (2017) 130 (Supplement 1): 2601.

https://doi.org/10.1182/blood.V130.Suppl_1.2601.2601

Published: 2017

Journal Articles

Integrin alpha6-Deletion Induces Apoptosis and Src Signaling Changes in Acute Lymphoblastic Leukemia Cells

Eun Ji Gang, MD PhD, Hye Na Kim, Johanna Scott, PhD, Matthew J Oberley, MDPhD, Etan Orgel, MD MS, Steven D. Mittelman, MDPhD, Yao-Te Hsieh, PhD, Markus Muschen, MD, Deepa Bhojwani, MD, Daniel Braas, PhD, Thomas Graeber, PhD, Nora Heisterkamp, PhD, Yong-Mi Kim, MD MPH, PhD

Blood (2017) 130 (Supplement 1): 3878.

https://doi.org/10.1182/blood.V130.Suppl_1.3878.3878

Published: 2017

Journal Articles

Targeting Primary Pre-B Cell Acute Lymphoblastic Leukemia and CD19-Negative Relapses Using Trivalent CAR T Cells

Kristen Fousek, BS, MS, Junji Watanabe, PhD, Ann George, PhD, Xingyue An, BS, Hebatalla Samaha, MS, Shoba Alaska Navai, MD, Tiara T Byrd, PhD, Albert Jang, BS, Hye Na Kim, Sujith Joseph, Matthew Baker, Navin Varadarajan, PhD, Meenakshi G. Hegde, MD, Yong-Mi Kim, MD MPH, PhD, Nora Heisterkamp, PhD, Hisham Abdel-Azim, Nabil Ahmed, MD

Blood (2017) 130 (Supplement 1): 4614.

https://doi.org/10.1182/blood.V130.Suppl_1.4614.4614

Published: 2017

Journal Articles

Overcoming Drug Resistance of Pre-B ALL Cells By Targeting Integrin alpha6 Associated Cell-Adhesion Mediated Drug Resistance Using a Novel Antibody, P5G10

EunJi Gang, MDPhD, Yao-Te Hsieh, PhD, Hye Na Kim, Yann Duchartre, PhD, Shishido Stephanie, PhD, Markus Muschen, MD, Elizabeth Wayner, PhD, Nora Heisterkamp, PhD, Halvard Bonig, MD MA, Yong-Mi Kim, MDPhDMPH

Blood (2015) 126 (23): 2525.

https://doi.org/10.1182/blood.V126.23.2525.2525

Published: 2015

Journal Articles

The PI3Kdelta Inhibitor, CAL-101, Inhibits Migration of Primary Pre-B ALL to SDF1alpha: Treatment Implications for Overcoming Cell-Adhesion-Mediated Drug Resistance

EunJi Gang, MDPhD, Hye Na Kim, Yann Duchartre, PhD, Stephanie Nicole Shishido, PhD, Sajad Khazal, MD, Etai Adam, MD, Nour Abdel-Azim, Chintan Parekh, MBBS, Hisham Abdel-Azim, MD, Deepa Bhojwani, MD, Nora Heisterkamp, PhD, Alan S. Wayne, MD, Yong-Mi Kim, MDPhDMPH

Blood (2015) 126 (23): 2526.

https://doi.org/10.1182/blood.V126.23.2526.2526

Published: 2015

Journal Articles

Galectin-3 Inhibition As a Novel Therapeutic Approach in Acute Lymphoblastic Leukemia (ALL)

Somayeh Samadzadeh Tarighat, PhD, Fei Fei, Khuchtumur Bum-Erdene, Helen Blanchard, John Groffen, Nora Heisterkamp, PhD

Blood (2015) 126 (23): 2047.

https://doi.org/10.1182/blood.V126.23.2047.2047

Published: 2015

Journal Articles

Megakaryocytes Support Viability Proliferation and Protection of Primary Pre-B ALL Cells from Chemotherapy

Stephanie Nicole Shishido, PhD, EunJi Gang, MDPhD, Ruth Xu, Hye Na Kim, Yann Duchartre, PhD, Steven D. Mittelman, MDPhD, Hisham Abdel-Azim, MD, Matthew J Oberley, MDPhD, Nora Heisterkamp, PhD, Yong-Mi Kim, MDPhDMPH

Blood (2015) 126 (23): 3763.

https://doi.org/10.1182/blood.V126.23.3763.3763

Published: 2015

Journal Articles

PI3Kdelta Inhibitor, CAL-101, De-Adheres Primary Pre-B ALL from VCAM-1 and Induces Apoptosis in Primary Pre-B ALL

Sajad Khazal, MD, Enzi Jiang, MD PhD, Stephanie Shishido, Osanna Kosoyan, Kim Hye-Na, Alexa Velasquez, Yao-Te Hsieh, Hisham Abdel-Azim, MD, Ann M Mohrbacher, MD, Akil Merchant, MD, Alan S. Wayne, MD, Nora Heisterkamp, PhD, Yong-Mi Kim, MD MPH, PhD

Blood (2014) 124 (21): 3715.

https://doi.org/10.1182/blood.V124.21.3715.3715

Published: 2014

Journal Articles

Targeting Survivin In Recalcitrant Acute Lymphoblastic Leukemia

Eugene Park, Enzi Jiang, MD, PhD, Yao-Te Hsieh, Lars Klemm, Cihangir Duy, Edward M. Conway, MD, PhD, FRCPC, MBA, Louis M. Pelus, PhD, John Crispino, PhD, Mignon L. Loh, M.D., Eun-Suk Kang, MD, PhD, Hong-Hoe Koo, MD, PhD, Allen Yang, MD, PhD, Nora Heisterkamp, PhD, Michael Kahn, PhD, Markus Muschen, MD, Yong-Mi Kim, MD, MPH

Blood (2010) 116 (21): 3263.

https://doi.org/10.1182/blood.V116.21.3263.3263

Published: 2010

Journal Articles

Role of Survivin in Drug Resistant B-Cell Acute Lymphoblastic Leukemia.

Eugene Park, Enzi Jiang, MD, PhD, Gregor von Levetzow, Cihangir Duy, Lars Klemm, Yao-Te Hsieh, Asha Kadavallore, Hong Ma, PhD, Yi Zhao, MD, Cu Nguyen, John Groffen, PhD, Nora Heisterkamp, PhD, Markus Muschen, MD, Michael Kahn, PhD, Yong-Mi Kim, MD

Blood (2009) 114 (22): 10.

https://doi.org/10.1182/blood.V114.22.10.10

Published: 2009

Journal Articles

Targeting Survivin Using ICG-001 May Overcome Drug Resistance in Primary B-Cell Acute Lymphoblastic Leukemia.

Enzi Jiang, MD, PhD, Eugene Park, Carlton Scharman, Yao-Te Hsieh, Asha Kadavallore, Cu Nguyen, Yi Zhao, MD, Michael McMillan, PhD, John Groffen, PhD, Nora Heisterkamp, PhD, Markus Muschen, MD, Michael Kahn, PhD, Yong-Mi Kim, MD

Blood (2009) 114 (22): 3072.

https://doi.org/10.1182/blood.V114.22.3072.3072

Published: 2009

Journal Articles

Preclinical Evaluation of Adjuvant Therapy with AMD3100 for Drug Resistant Philadelphia Chromosome Positive and Negative ALL

Enzi Jiang, MD, PhD, Min Yu, MD, PhD, Yao-Te Hsieh, Brian DeLaTorre, Asha Kadavallore, Carlton Scharman, Eugene Park, Allen S. Yang, MD, PhD, Markus Muschen, MD, John Groffen, PhD, Nora Heisterkamp, PhD, Yong-Mi Kim, MD

Blood (2008) 112 (11): 2922.

https://doi.org/10.1182/blood.V112.11.2922.2922

Published: 2008

Journal Articles

Adipocytes Secrete Factors That Cause Leukemia Drug Resistance.

James W Behan, Jason P Yun, Marina P Proektor, Ehsan A Ehsanipour, Anna Butturini, MD, Nora Heisterkamp, PhD, Steven D Mittelman, MD, PhD

Blood (2008) 112 (11): 1346.

https://doi.org/10.1182/blood.V112.11.1346.1346

Published: 2008

Journal Articles

Pre-B Cell Receptor Signaling Prevents Leukemic Transformation by BCR-ABL1 .

Daniel Trageser, Lars Klemm, Sebastian Herzog, Yong-mi Kim, MD, Cihangir Duy, Wolf-Karsten Hofmann, MD, John Groffen, PhD, Nora Heisterkamp, PhD, Hassan Jumaa, PhD, Markus Muschen, MD

Blood (2007) 110 (11): 2795.

https://doi.org/10.1182/blood.V110.11.2795.2795

Published: 2007

NARROW

Pre-BCR Surrogate Light Chain Components VPREB1 and IGLL1 Function As Pre-BCR-Independent Tumor Suppressors in Acute Lymphoblastic Leukemia

CAR T Cell Relapse CD19 Negative ALL Cells Express Integrins and Integrin Blockade Can Prolong Survival In Vivo

Integrin alpha6-Deletion Induces Apoptosis and Src Signaling Changes in Acute Lymphoblastic Leukemia Cells

Targeting Primary Pre-B Cell Acute Lymphoblastic Leukemia and CD19-Negative Relapses Using Trivalent CAR T Cells

Overcoming Drug Resistance of Pre-B ALL Cells By Targeting Integrin alpha6 Associated Cell-Adhesion Mediated Drug Resistance Using a Novel Antibody, P5G10

The PI3Kdelta Inhibitor, CAL-101, Inhibits Migration of Primary Pre-B ALL to SDF1alpha: Treatment Implications for Overcoming Cell-Adhesion-Mediated Drug Resistance

Galectin-3 Inhibition As a Novel Therapeutic Approach in Acute Lymphoblastic Leukemia (ALL)

Megakaryocytes Support Viability Proliferation and Protection of Primary Pre-B ALL Cells from Chemotherapy

PI3Kdelta Inhibitor, CAL-101, De-Adheres Primary Pre-B ALL from VCAM-1 and Induces Apoptosis in Primary Pre-B ALL

Targeting Survivin In Recalcitrant Acute Lymphoblastic Leukemia

Role of Survivin in Drug Resistant B-Cell Acute Lymphoblastic Leukemia.

Targeting Survivin Using ICG-001 May Overcome Drug Resistance in Primary B-Cell Acute Lymphoblastic Leukemia.

Preclinical Evaluation of Adjuvant Therapy with AMD3100 for Drug Resistant Philadelphia Chromosome Positive and Negative ALL

Adipocytes Secrete Factors That Cause Leukemia Drug Resistance.

Pre-B Cell Receptor Signaling Prevents Leukemic Transformation by BCR-ABL1 .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only